BCA Assay Protocol: Principles and Step-by-Step Instructions

The bicinchoninic acid (BCA) assay is a colorimetric method for quantifying total protein concentration in solution, based on the reduction of Cu²⁺ to Cu⁺ by peptide bonds under alkaline conditions, followed by chelation of Cu⁺ with BCA to form a purple-colored complex with maximum absorbance at 562 nm. This assay is particularly useful when working with samples containing detergents (up to 5% SDS, Triton X-100, or Tween-20), chaotropic agents (e.g., urea up to 3 M), or when higher sensitivity than the Bradford assay is needed (detection range typically 20–2,000 µg/mL). The BCA assay is widely employed in proteomics sample preparation, cell lysate analysis, and quality control for downstream applications such as SDS-PAGE, Western blotting, and mass spectrometry.

At a Glance

Scientific Principle of the BCA Assay

The BCA assay relies on two sequential chemical reactions. First, under alkaline conditions (provided by the bicinchoninic acid reagent's sodium carbonate/bicarbonate buffer, pH ~11.25), proteins reduce Cu²⁺ to Cu⁺. The amount of Cu⁺ produced is proportional to the number of peptide bonds present, making the assay responsive to protein concentration rather than specific amino acid composition. Second, each Cu⁺ ion chelates two molecules of BCA, forming a stable, water-soluble purple complex that absorbs strongly at 562 nm.

The reaction is temperature-dependent. At 37°C, the color development reaches a stable plateau after approximately 30 minutes, allowing endpoint measurement. At 60°C, the reaction accelerates (15 minutes) but may increase background from reducing agents. Room temperature incubation requires 2 hours but minimizes interference from some compounds. The absorbance at 562 nm is linear with protein concentration across the working range, enabling quantification by comparison to a standard curve prepared from a known protein (typically bovine serum albumin, BSA).

The BCA assay is more tolerant of detergents and chaotropic agents than the Bradford assay, but it is susceptible to interference from reducing agents (e.g., DTT, β-mercaptoethanol) and chelating agents (e.g., EDTA) that compete for copper ions. Understanding these chemical interactions is essential for accurate quantification, particularly in complex sample matrices such as conditioned culture media or nanoparticle corona preparations.

Materials and Instrumentation Choices

Reagent Systems

Commercial BCA assay kits (e.g., Pierce BCA Protein Assay Kit, Thermo Scientific) provide standardized reagents with lot-to-lot consistency. These kits include:

• Reagent A: Sodium carbonate, sodium bicarbonate, BCA, and sodium tartrate in 0.1 M sodium hydroxide
• Reagent B: 4% copper(II) sulfate pentahydrate solution
• Working reagent (WR): Prepared by mixing Reagent A and Reagent B at a 50:1 ratio (v/v)

Alternatively, researchers can prepare reagents from individual chemicals, though this requires careful pH adjustment and quality control. For most applications, commercial kits are recommended due to their validated stability and reproducibility.

Protein Standards

Bovine serum albumin (BSA) is the most common standard, provided as a 2 mg/mL ampule in many commercial kits. However, BSA may overestimate protein concentration in samples with different amino acid compositions because it is rich in cysteine, tyrosine, and tryptophan residues that contribute to copper reduction. For samples with known protein composition (e.g., purified recombinant proteins), using the same purified protein as a standard improves accuracy. For complex mixtures (e.g., cell lysates), BSA is acceptable as a relative standard.

Instrumentation

• Microplate reader: For 96-well plate format, requires absorbance measurement at 562 nm. Filter-based readers need a 562 nm filter; monochromator-based readers can measure at 562 nm directly.
• Spectrophotometer: For cuvette-based assays, requires a visible-light spectrophotometer capable of 562 nm measurement.
• Incubator: Dry-air incubator set to 37°C or 60°C. A water bath can be used but must be sealed to prevent evaporation.
• Multichannel pipette: For efficient plate-based assays, an 8- or 12-channel pipette (20–200 µL range) is recommended.
• Microcentrifuge: For brief centrifugation to collect condensation and remove bubbles before measurement.

Plate vs. Cuvette Format

Controls and Standards

Standard Curve Preparation

Prepare BSA standards in the same buffer as the samples to account for buffer effects on color development. A typical standard curve for the standard protocol (20–2,000 µg/mL) includes:

For the enhanced protocol (0.5–50 µg/mL), dilute the 2 mg/mL BSA stock serially to create standards at 50, 25, 12.5, 6.25, 3.125, 1.5625, 0.78125, and 0 µg/mL.

Blank and Background Controls

• Reagent blank: Working reagent plus diluent only (no protein). Used to zero the spectrophotometer.
• Sample blank: If samples contain interfering substances (e.g., reducing agents), prepare a control with sample buffer plus working reagent to subtract background absorbance.
• Positive control: A known protein concentration (e.g., 1 mg/mL BSA) to verify assay performance.

Conceptual Workflow

Step 1: Sample Preparation

Dilute samples to fall within the linear range of the assay. For cell lysates, typical dilutions are 1:5 to 1:20 in lysis buffer. For conditioned culture media, be aware that BCA can overestimate protein concentrations due to interfering components such as phenol red, serum proteins, or secreted metabolites [2]. Otsuka et al. (2025) demonstrated that conventional BCA quantification of concentrated culture media can lead to inconsistent protein loading in mass spectrometry-based proteomics, and they recommend a concentration rate-based normalization method that adjusts sample volumes according to the ultrafiltration concentration ratio [2].

For nanoparticle corona samples, the protein concentration is typically low, and the presence of nanoparticles can scatter light, potentially interfering with absorbance measurements. Saorin et al. (2026) emphasized that sample preparation protocols significantly influence protein recovery and representation in corona studies, highlighting the need for method standardization [1].

Step 2: Working Reagent Preparation

Calculate the total volume of working reagent needed: (number of standards + number of samples + number of blanks) × (number of replicates) × (volume per well or cuvette). Prepare working reagent by mixing 50 parts Reagent A with 1 part Reagent B. For example, for 50 wells requiring 200 µL each, prepare 10 mL of working reagent: 9.8 mL Reagent A + 0.2 mL Reagent B.

The working reagent is stable for approximately 24 hours at room temperature when protected from light. Do not prepare working reagent more than 1 day in advance.

Step 3: Assay Setup

Microplate format:

1. Pipette 25 µL of each standard, sample, or blank into a 96-well microplate (use clear, flat-bottom plates).
2. Add 200 µL of working reagent to each well.
3. Mix thoroughly on a plate shaker for 30 seconds.
4. Cover the plate with sealing film or a lid to prevent evaporation.
5. Incubate at 37°C for 30 minutes (standard protocol) or 60°C for 15 minutes (enhanced protocol).
6. Cool to room temperature (approximately 5 minutes).
7. Measure absorbance at 562 nm within 10 minutes of cooling.

Cuvette format:

1. Pipette 1 mL of each standard, sample, or blank into a cuvette.
2. Add 2 mL of working reagent to each cuvette.
3. Mix by inversion or vortexing.
4. Incubate at 37°C for 30 minutes.
5. Cool to room temperature.
6. Measure absorbance at 562 nm.

Step 4: Standard Curve Generation

1. Subtract the average blank absorbance from all standard and sample readings.
2. Plot corrected absorbance (y-axis) versus protein concentration (x-axis) for the standards.
3. Perform linear regression (do not force through zero unless the blank is exactly zero).
4. The R² value should be ≥0.98 for an acceptable standard curve.

Step 5: Sample Concentration Calculation

1. For each sample, use the linear regression equation to calculate the protein concentration from the corrected absorbance.
2. Multiply by the dilution factor to obtain the original sample concentration.
3. Report concentrations with appropriate significant figures (e.g., 1.25 mg/mL, not 1.2500 mg/mL).

Quality Checks

Standard Curve Acceptance Criteria

• Linearity: R² ≥ 0.98. Lower R² values indicate pipetting errors, incomplete mixing, or expired reagents.
• Blank absorbance: Should be <0.2 AU at 562 nm. Higher values suggest reagent contamination or degradation.
• Standard recovery: Each standard should fall within ±10% of the expected value when back-calculated from the regression.

Replicate Consistency

• Coefficient of variation (CV): For triplicate measurements, CV should be <10%. Higher CV indicates pipetting variability or sample heterogeneity.
• Outlier identification: Use Grubbs' test or visual inspection to identify and exclude outliers (e.g., absorbance values >2 standard deviations from the mean).

Positive Control Verification

The positive control (e.g., 1 mg/mL BSA) should yield a concentration within ±10% of the expected value. Deviations suggest problems with reagent preparation, incubation conditions, or standard curve accuracy.

Result Interpretation

Absorbance Values

• Within range: Sample absorbance falls between the lowest and highest standard (after blank subtraction). Concentration can be calculated directly.
• Below range: Sample absorbance is lower than the lowest standard. Dilute the sample less (or concentrate it) and repeat.
• Above range: Sample absorbance is higher than the highest standard. Dilute the sample further and repeat.

Color Observations

• Purple color: Normal reaction. Intensity correlates with protein concentration.
• Green or brown color: May indicate interference from reducing agents or chelating agents.
• Precipitate formation: Can occur with high salt concentrations (>1 M NaCl) or extreme pH (<2 or >12).

Compatibility Considerations

The BCA assay is compatible with many common laboratory reagents, but certain compounds interfere:

For samples containing interfering substances, consider:

• Diluting the sample to reduce interferent concentration
• Using a compatible protein quantification method (e.g., Bradford assay for samples with low detergent concentrations)
• Precipitating proteins (e.g., with acetone or TCA) and resuspending in a compatible buffer

Troubleshooting

Limitations

Interference from Reducing Agents

The BCA assay is incompatible with reducing agents at concentrations commonly used in protein sample preparation (e.g., 5–10 mM DTT for disulfide reduction). Reducing agents directly reduce Cu²⁺ to Cu⁺, producing a false-positive signal. If reducing agents are present, either:

• Remove them by dialysis, desalting columns, or protein precipitation
• Use a reducing-agent-compatible assay (e.g., Bradford assay, which is less affected by reducing agents)
• Use a modified BCA protocol with iodoacetamide pretreatment to alkylate reducing agents

Protein-to-Protein Variability

Different proteins reduce copper at different rates due to variations in amino acid composition. Proteins rich in cysteine, tyrosine, and tryptophan produce higher absorbance per unit mass than proteins poor in these residues. For absolute quantification, use a standard of the same purified protein. For relative quantification (e.g., comparing samples of similar composition), BSA is acceptable.

Interference from Lipids and Carbohydrates

High concentrations of lipids (>1%) or carbohydrates (>10%) can interfere with the BCA reaction. Lipid-rich samples (e.g., membrane fractions) may require delipidation prior to quantification. Carbohydrate-rich samples (e.g., glycoproteins) may show elevated absorbance due to the reducing ends of sugars.

Temperature Sensitivity

The BCA reaction is temperature-dependent. Incubation at temperatures below 37°C slows color development, while temperatures above 37°C accelerate it but may increase background. Use a calibrated incubator and avoid temperature gradients across the plate.

Limited Dynamic Range

The standard protocol has a linear range of 20–2,000 µg/mL. Samples outside this range require dilution or concentration. The enhanced protocol extends the lower limit to 0.5 µg/mL but requires longer incubation at 60°C, which may increase interference from reducing agents.

Documentation and Reporting

Laboratory Notebook Entry

Record the following information for each BCA assay:

• Date and operator name
• Sample description and preparation details (dilution factor, buffer composition)
• Standard concentrations and source (e.g., BSA lot number)
• Working reagent preparation (volumes of Reagent A and B, date prepared)
• Incubation temperature and time
• Plate layout or cuvette arrangement
• Raw absorbance values (before and after blank subtraction)
• Standard curve equation and R² value
• Calculated sample concentrations with dilution factors
• Any deviations from the standard protocol

Data Reporting

When reporting BCA assay results in publications or reports, include:

• The assay format (microplate or cuvette)
• The standard used (e.g., BSA, Pierce BCA Protein Assay Kit)
• The incubation conditions (temperature and time)
• The linear range and R² value of the standard curve
• The number of replicates and variability (e.g., mean ± SD)
• Any sample preparation steps (dilution, concentration, precipitation)

Biosafety Considerations

The BCA assay is a routine biochemical procedure that does not involve propagation of microorganisms. Standard BSL-1 practices apply when working with non-pathogenic samples such as cell lysates from immortalized cell lines or purified proteins. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition, provides authoritative guidance for risk assessment and containment in microbiological laboratories [5].

Key biosafety practices for BCA assays:

• Wear laboratory coat, gloves, and eye protection when handling samples and reagents.
• Work in a designated laboratory area with good ventilation.
• Dispose of samples and reagents according to institutional hazardous waste guidelines.
• Decontaminate work surfaces with 70% ethanol or 10% bleach after use.
• If working with recombinant proteins or nucleic acids, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [6].

The BCA reagents themselves are not classified as hazardous waste in most jurisdictions, but copper sulfate is toxic to aquatic organisms and should be disposed of according to local environmental regulations.

Frequently Asked Questions

1. Can I use the BCA assay with samples containing DTT or β-mercaptoethanol?

The BCA assay is incompatible with reducing agents at concentrations commonly used in protein biochemistry. DTT at concentrations above 1 mM and β-mercaptoethanol above 10 mM will produce false-positive signals by directly reducing Cu²⁺ to Cu⁺. If reducing agents are present, remove them by dialysis, desalting columns, or protein precipitation before quantification. Alternatively, use the Bradford assay, which is less affected by reducing agents.

2. Why does my standard curve have poor linearity (R² < 0.98)?

Poor linearity typically results from pipetting errors, incomplete mixing, or temperature gradients across the plate. Ensure that all standards and samples are pipetted accurately, mix the plate thoroughly on a shaker for 30 seconds after adding working reagent, and incubate in a calibrated incubator without stacking plates (which can create temperature gradients). If using a microplate, avoid edge wells if the incubator has uneven heating.

3. How do I quantify protein in conditioned culture media without overestimation?

Conventional BCA assays can overestimate protein concentrations in concentrated culture media due to interfering components such as phenol red, serum proteins, or secreted metabolites. Otsuka et al. (2025) recommend a concentration rate-based normalization method that adjusts sample volumes according to the ultrafiltration concentration ratio, ensuring more consistent protein loading across samples [2]. Alternatively, precipitate proteins from the media (e.g., with acetone or TCA) and resuspend in a compatible buffer before quantification.

4. What is the difference between the standard and enhanced BCA protocols?

The standard protocol (37°C for 30 minutes) has a linear range of 20–2,000 µg/mL and is suitable for most applications. The enhanced protocol (60°C for 15 minutes) extends the lower limit to 0.5–50 µg/mL, allowing quantification of dilute samples. However, the enhanced protocol is more susceptible to interference from reducing agents and may show higher background absorbance. Use the standard protocol unless you need to quantify low-concentration samples.

References and Further Reading

1. Saorin A, Martinez-Serra A, Henry M, Meleady P, Monopoli MP. Mass Spectrometry Proteomics of the Nanoparticle Corona Is Highly Dependent on Sample Preparation Protocol. 2026. PubMed ID: 41889290. https://pubmed.ncbi.nlm.nih.gov/41889290/ Discusses the impact of sample preparation protocols on protein recovery and representation in nanoparticle corona studies, highlighting the need for method standardization.

2. Otsuka T, Hatano A, Matsumoto M, Matsui H. A robust protocol for proteomic profiling of secreted proteins in conditioned culture medium. 2025. PubMed ID: 41018846. https://pubmed.ncbi.nlm.nih.gov/41018846/ Demonstrates that BCA assays can overestimate protein concentrations in concentrated culture media and presents a concentration rate-based normalization method for improved accuracy.

3. Roig-Kuhn FC, Klaassen RV, Koopmans FTW, Koolman TSZ, Smit AB, Spijker S. A Tiered Approach to Human Synapse Proteomics: Optimized LC-MS/MS Analysis of Whole-Tissue Lysate and Synaptosome Preparations from Frozen Post-Mortem Brain Samples. 2026. PubMed ID: 42041603. https://pubmed.ncbi.nlm.nih.gov/42041603/ Describes optimized sample preparation protocols for neuroproteomics, including protein quantification considerations for brain tissue lysates.

4. Peternell C, Noll P, Brümmer-Rolf A, Henkel M. Making GFP count: a validated framework for absolute protein quantification in precision fermentation. 2026. PubMed ID: 41639258. https://pubmed.ncbi.nlm.nih.gov/41639258/ Presents a validated method for protein quantification using fluorescence, with relevance to standard curve preparation and method validation.

5. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. https://www.cdc.gov/labs/bmbl/index.html Authoritative principles for risk assessment, containment, decontamination, and microbiological laboratory practice.

6. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/ Institutional and biosafety framework for recombinant and synthetic nucleic acid research.

7. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/ Searchable collection of authoritative biomedical books and methods references.

Related Articles

• Bradford Assay Protocol: Step-by-Step for Protein Quantification
• Sandwich ELISA Protocol: Step-by-Step Guide for Antigen Detection
• Immunofluorescence Assay: Principles and Protocol for Protein Localization
• BCA Assay Principle: How the Bicinchoninic Acid Reaction Works
• Enzyme Activity Assay: Principles and Protocol for Measuring Catalytic Activity
• Bradford vs BCA Assay: Which Protein Quantification Method to Choose?